Certainty assessment | No. of patients | Effect | Certainty | Importance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Anthelmintic | Placebo | Relative (95% CI) | Absolute (95% CI) | ||
Height (cm) | ||||||||||||
5 | Randomised trials | Serious a | Not serious | Not serious | Not serious | All plausible residual confounding would suggest spurious effect, while no effect was observed | 1240 | 1068 | - | MD 0.18 cm fewer (0.6 fewer to 0.24 more) | ⨁⨁⨁⨁ High | CRITICAL |
Height-for-age (HAZ) or length-for-age (LAZ) | ||||||||||||
2 | Randomised trials | Serious b | Not serious | Not serious | Not serious | None | 477 | 468 | - | MD 0.02 more (0.06 fewer to 0.1 more) | ⨁⨁⨁◯ Moderate | CRITICAL |